Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adjunctive Therapies for Sepsis and Septic Shock.

Breen1, Tunkel

  • 1MCP Hahnemann University, 3300 Henry Avenue, Philadelphia, PA 19129, USA.

Current Infectious Disease Reports
|November 30, 2000
PubMed
Summary

Sepsis treatment advances are few, with survival rates around 55-60%. This review explores new therapies like cytokine modifiers and enhanced oxygen delivery to improve outcomes for sepsis patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic Meningitis.

Current infectious disease reports·2000
Same author

Septic Shock and Toxic Shock: Do Adjunctive Therapies Improve Outcome?

Current infectious disease reports·2000
Same author

Changing Epidemiology of Bacterial Meningitis in the United States.

Current infectious disease reports·2000
Same author

Clinical Trials Report.

Current infectious disease reports·2000
Same author

Impact of Antimicrobial Resistance on the Treatment of Invasive Pneumococcal Infections.

Current infectious disease reports·2000
Same author

Forming electrical networks in three dimensions by self-assembly

Science (New York, N.Y.)·2000

Area of Science:

  • Critical Care Medicine
  • Immunology
  • Infectious Diseases

Background:

  • Sepsis involves a complex inflammatory cascade after infection, leading to varied patient outcomes from mild illness to organ failure.
  • Despite intense research, effective sepsis treatments remain limited, with overall survival rates stagnating at 55-60%.

Purpose of the Study:

  • To review recent therapeutic advances for sepsis syndrome.
  • To highlight novel treatment modalities aimed at improving patient survival.

Main Methods:

  • Review of recent literature on sepsis therapy.
  • Focus on specific treatment strategies including cytokine modifiers, oxygen delivery, and nutritional support.

Main Results:

  • Advances in sepsis treatment have been incremental, with slight survival improvements in specific subgroups.
  • Current research explores adjunctive therapies to combat the inflammatory response and support organ function.

Conclusions:

  • New therapeutic approaches, including cytokine modifiers and enhanced oxygen delivery, offer potential for improved sepsis survival.
  • Parenteral nutrition and granulocyte colony-stimulating factor in leukopenic patients are also being investigated as supportive measures.

Related Experiment Videos